Baxter International Inc

Type: Company
Name: Baxter International Inc
First reported 3 hours ago - Updated 3 hours ago - 1 reports

Five major Minnesota businesses benefiting from tax breaks and government aid

ST. PAUL, Minn. The funding that will help Rochester and the non-profit Mayo Clinic develop a destination medical center got the most headlines. But millions in subsidies also are headed to the Mall of America, and three members of the S&P 500--3M, Baxter ... [Published Minnesota Public Radio - 3 hours ago]
First reported 9 hours ago - Updated 9 hours ago - 1 reports

Berko:

My daughter owns a profitable business in another state and has 87 employees. Please don’t mention the company or product, because it might compromise her chances of obtaining an export license for nonstrategic industrial machinery, which is currently ... [Published Des Moines Business Record - 9 hours ago]
First reported 10 hours ago - Updated 10 hours ago - 1 reports

Pharma executives to meet at Pharma Integrates in November

More than 200 strategy level pharmaceutical executives will gather at on 2627 November at the Riverbank Park Plaza, London, to debate Strategically transforming pharma business relationships. The focus will be on examining how such collaborations are ... [Published Manufacturing Chemist - 10 hours ago]
First reported 13 hours ago - Updated 13 hours ago - 1 reports

Download: Presentation ‘The benefit risk mindset & evolving management strategies’

Dr Robin Gellar, Director of Risk Management of Global Pharmacovigilance, Baxter International, spoke at this year’s World Drug Safety Congress Americas. I thought you might be interested in downloading his presentation on ‘The benefit risk mindset & ... [Published Terrapinn - 13 hours ago]
First reported May 23 2013 - Updated May 23 2013 - 1 reports

Highest Dividend Yield in the Health Care Equipment Industry Detected for Baxter International (BAX, SNN, STJ)

(Financial News Network On) Below are the three companies in the Health Care Equipment industry with the highest dividend yields. Dividends can enhance returns for investors seeking income in addition to capital gains. Baxter International (NYSE:BAX) ... [Published Individual.com - May 23 2013]
First reported May 23 2013 - Updated May 23 2013 - 1 reports

Small in Stature: New Technology from Baxter Makes an Impact

Intravascular (IV) connectors are small medical devices that can have a big impact.IV connectors allow connection and disconnection between the IV tubing and the catheter that is inserted into a patient's bloodstream. When connected, these devices form ... [Published Zecco - May 23 2013]
First reported May 23 2013 - Updated May 23 2013 - 1 reports

Our View: Forget tax slams; plenty of aid coming

Gov. Mark Dayton and the DFL Legislature are taking a lot of heat largely from the business community for adding a fourth income-tax tier thats expected to tap the wealthiest 2 percent of Minnesotans for about $2 billion.But did you know this? Dayton ... [Published St. Cloud Times - May 23 2013]
First reported May 22 2013 - Updated May 22 2013 - 1 reports

Form 4 BAXTER INTERNATIONAL For: May 20 Filed by: Bufalino Sebastian J

StreetInsider.com - Form 4 BAXTER INTERNATIONAL For: May 20 Filed by: Bufalino Sebastian J ... [Published Street Insider - May 22 2013]
First reported May 22 2013 - Updated May 22 2013 - 2 reports

Buzzy Takes the Sting Out of Shots

In her lecture “Hacking Healthcare: How Makers can Save Medicine” at the 2013 Bay Area Maker Faire, Dr. Amy Baxter, an Atlanta-based pediatrician and pain researcher, told the story of taking her 4-year-old son in for a routine vaccination. Like ... [Published Mashable! - May 22 2013]
First reported May 21 2013 - Updated May 22 2013 - 2 reports

Novartis AG (NVS) Ramps Up Alzheimer's Drug Pursuit as Rivals Fail

Staying up-to-date has never been simpler. Sign up for the today! Novartis AG (NOVN) plans to ramp up its research in Alzheimerâs disease, a potential $20 billion market lacking a major contender and littered with three high-profile drug failures in the ... [Published BioSpace - May 22 2013]
First reported May 21 2013 - Updated May 22 2013 - 4 reports

Europe approves Baxter/Halozyme's HyQvia

The European Commission has given the green light to Baxter International and Halozyme Therapeutics' HyQvia as replacement therapy for adults with primary and secondary immunodeficiencies.HyQvia is a combination of human normal immunoglobulin and recombinant ... [Published Pharma Times - May 22 2013]
First reported May 20 2013 - Updated May 21 2013 - 5 reports

Baxter International, Inc. (BAX) to Present at the Deutsche Bank (DB) 38th Annual dbAccess Health Care Conference

Staying up-to-date has never been simpler. Sign up for the today! Baxter International Inc. (NYSE: BAX) announced today that it will present at the Deutsche Bank 38th Annual dbAccess Health Care Conference on Wednesday, May 29, 2013 at 7:00 a.m. (CT). ... [Published BioSpace - May 21 2013]

Quotes

...and Lafley to French general and statesman Charles de Gaulle, who moved in and out of military service and politics many times in his career. "Each time he came back it was for a short-term stay but he had a tremendously powerful impact."
...as outside financial and legal advisors, has determined that privately held investment firm Royalty Pharma's revised offer (“Royalty Pharma Offer ") announced on Monday May 20, 2013 to acquire all of Elan's shares for $12.50 per share through its shell subsidiary Echo Pharma Acquisition Limited, substantially undervalues the company."
"We believe these findings make a solid case for continued exploration of bexarotene as a therapeutic treatment for Alzheimer's disease" Dr. Rada Koldamova, who led the study, also published in Science, said in a statement

More Content

All (986) | News (723) | Reports (30) | Blogs (123) | Audio/Video (2) | Fact Sheets (12) | Press Releases (95)
sort by: Date | Relevance
Five major Minnesota businesses benefiting from... [Published Minnesota Public Radio - 3 hours ago]
Lafley at P&G, Ullman at Penney: When Does It M... [Published Forbes.com - 4 hours ago]
Should You Avoid Covidien plc (COV)? [Published InsiderMonkey.com - 4 hours ago]
Berko: [Published Des Moines Business Record - 9 hours ago]
Pharma executives to meet at Pharma Integrates ... [Published Manufacturing Chemist - 10 hours ago]
Download: Presentation ‘The benefit risk mindse... [Published Terrapinn - 13 hours ago]
YMCA of the USA (Y-USA) holds National Healthy ... [Published Westside Gazette - 15 hours ago]
Omeros Announces INDA for OMS824 Cleared by FDA... [Published BioMedReports - 22 hours ago]
Dog Walking Etiquette [Published Primary Times - May 24 2013]
Labs reject dramatic findings on cancer drug in... [Published Yahoo! News - May 23 2013]
Labs reject dramatic findings on cancer drug in... [Published CNBC - May 23 2013]
Highest Dividend Yield in the Health Care Equip... [Published Individual.com - May 23 2013]
Baxter to Present at the Goldman Sachs 34th Ann... [Published EON Business - May 23 2013]
Baxter to Present at the Goldman Sachs 34th Ann... [Published Business Wire Science: Science News - May 23 2013]
Baxter to Present at the Goldman Sachs 34th Ann... [Published Business Wire Manufacturing News - May 23 2013]
Baxter to Present at the Goldman Sachs 34th Ann... [Published Business Wire Health News - May 23 2013]
Ligand to Present at Upcoming Investor Conferences [Published Reuters - May 23 2013]
LIGAND PHARMACEUTICALS INC. : Ligand to Present... [Published 4 Traders - May 23 2013]
Small in Stature: New Technology from Baxter Ma... [Published Zecco - May 23 2013]
Cutting Costs and, Literally, Corners [Published Pharmaceutical & Medical Packaging News - May 23 2013]
Our View: Forget tax slams; plenty of aid coming [Published St. Cloud Times - May 23 2013]
Form 4 BAXTER INTERNATIONAL For: May 20 Filed b... [Published Street Insider - May 22 2013]
Cooper Carry Continues to Expand Footprint of t... [Published Citybizlist - May 22 2013]
Buzzy Takes the Sting Out of Shots [Published Mashable! - May 22 2013]
Onconova Announces Presentation of Oral Rigoser... [Published Equities.com - May 22 2013]
Novartis AG (NVS) Ramps Up Alzheimer's Drug Pur... [Published BioSpace - May 22 2013]
Key Account Manager - Critical Care - Chennai [Published Siasat Daily - May 22 2013]
Cooper Carry Continues to Expand Footprint of t... [Published PRWeb - May 22 2013]
Buzzy Takes the Sting Out of Shots [Published Discovery Health - May 22 2013]
Alzheimer’s Disease New Drug to Prevent Dementia [Published The Guardian Express - May 22 2013]
1 2 3 4 5 6 7 8 9 10 ...
In Focus
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
Buzzy Takes the Sting Out of Shots [Published Mashable! - May 22 2013]
In her lecture “Hacking Healthcare: How Makers can Save Medicine” at the 2013 Bay Area Maker Faire, Dr. Amy Baxter, an Atlanta-based pediatrician and pain researcher, told the story of taking her 4-year-old son in for a routine vaccination. Like ...
Baxter International (BAX) Showing Bullish Tech... [Published MarketIntelligenceCenter.com - May 22 2013]
Baxter International Inc (NYSE: BAX) closed Tuesday's trading session at $73.04. In the past year, the stock has hit a 52-week low of $48.98 and 52-week high of $73.95. Baxter International (BAX) stock has been showing support around $72.06 and resistance ...
Immunoglobulins Market 2019 Demand in Primary I... [Published Zunia.org RSS - May 21 2013]
RnRMarketResearch.com adds Immunoglobulins Market to 2019 Demand in Primary Immunodeficiency (PI) and Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) potentially supplemented by approvals for Alzheimers disease new report on its database. ...
Jim Cramer: Buy Salesforce.com, Boston Scientif... [Published Wall St. Cheat Sheet - May 20 2013]
. What do you think about his picks?Salesforce.com  ( NYSE:CRM ): Jim Cramer ranked this stock a  Buy . Cramer previously ranked this stock a Buy on April 18, 2013. The stock’s 52-week high is $47.31, and its 52-week low is $30.05.NEW! Discover a new ...
Jim Cramer: Buy Salesforce.com, Boston Scientif... [Published Wall St. Cheat Sheet - May 20 2013]
Jim Cramer made the following calls on May 17, 2013. What do you think about his picks? Salesforce.com  ( NYSE:CRM ): Jim Cramer ranked this stock a  Buy . Cramer previously ranked this stock a Buy on April 18, 2013. The stock’s 52-week high is $47.31, ...
1 2 3 4 5 6 7 8 9 10 ...

Audio/Video

sort by: Date | Relevance
Baxter to Buy Competitor Gambro for $2.8 Billio... [Published TheStreet.com - YouTube - Dec 04 2012]
Baxter To Buy Gambro in $4B Deal [Published FOX Business - Video - Dec 04 2012]
1

Press Releases

sort by: Date | Relevance
Baxter to Present at the Goldman Sachs 34th Ann... [Published EON Business - May 23 2013]
Baxter to Present at the Goldman Sachs 34th Ann... [Published Business Wire Science: Science News - May 23 2013]
Baxter to Present at the Goldman Sachs 34th Ann... [Published Business Wire Manufacturing News - May 23 2013]
Baxter to Present at the Goldman Sachs 34th Ann... [Published Business Wire Health News - May 23 2013]
Chinese Dialysis Industry Discussed in New Huid... [Published Business Wire - May 21 2013]
1 2 3 4 5 6 7 8 9 10 ...
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2013 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.